Xinβ, a member of the Xin family of proteins, plays a critical role in the regulation of cardiac and skeletal muscle development. The protein is involved in the organization of actin cytoskeleton structures, crucial for cell adhesion, and the mechanical integrity of muscle cells. By participating in the formation and maintenance of intercalated discs in cardiac muscle cells, Xinβ contributes to the proper transmission of mechanical and electrical signals across the heart, facilitating synchronized heartbeats. In skeletal muscle, Xinβ's function is associated with the stabilization of neuromuscular junctions and the regulation of muscle fiber attachment, underscoring its importance in muscle strength and coordination. The precise mechanisms through which Xinβ exerts its effects involve interactions with various cytoskeletal and signaling molecules, indicating its role as a mediator in complex networks that govern muscle cell behavior and organ function.
The inhibition of Xinβ, therefore, represents a disruption to these critical physiological processes, potentially leading to compromised muscle function and structural integrity. Inhibition can occur through various mechanisms, including the interference with the protein's expression, post-translational modifications, or its interaction with other cellular components. For example, inhibiting the transcription or translation of Xinβ would directly reduce its availability within the cell, thereby affecting the structural support it provides to muscle cells. Additionally, post-translational modifications such as phosphorylation or ubiquitination, which are essential for the protein's functional activation or degradation, could be targeted to modulate Xinβ's activity indirectly. Furthermore, inhibition might involve disrupting the interaction between Xinβ and its binding partners, thereby impairing the assembly of functional complexes necessary for muscle integrity and signaling. Such mechanisms highlight the nuanced approaches through which Xinβ's activity can be modulated, reflecting the intricate balance of cellular processes that maintain muscle function and the potential consequences of disrupting these processes on muscle health and organismal physiology.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $229.00 | 33 | |
A toxin that binds to actin filaments, stabilizing them and preventing their disassembly, which can affect proteins like XIRP2 that are involved in actin binding. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
A compound that binds to the barbed ends of actin filaments, blocking polymerization and elongation, potentially disrupting XIRP2-actin interactions. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
An alkaloid that sequesters G-actin monomers, preventing their polymerization and potentially interfering with XIRP2's association with actin networks. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
An inhibitor of myosin light chain kinase which can affect actin-myosin interactions and consequently the functions of actin-binding proteins like XIRP2. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor which can alter actin cytoskeleton dynamics, potentially affecting XIRP2's role in actin-binding and cell structure maintenance. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
A myosin II inhibitor which can impair actin-myosin interactions and thus may indirectly disrupt XIRP2 associated processes. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $315.00 $1020.00 | 5 | |
An Arp2/3 complex inhibitor, leading to decreased actin polymerization which could alter the cellular context for XIRP2 activity. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
A formin inhibitor which impedes actin nucleation, thereby potentially affecting XIRP2's role in the actin cytoskeleton. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
A PKC inhibitor that might alter downstream actin cytoskeleton rearrangements, with possible indirect effects on XIRP2's function. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $48.00 $122.00 $432.00 $812.00 | 4 | |
An inhibitor of the N-WASP which is involved in actin polymerization; it may impact XIRP2's interaction with the actin cytoskeleton. |